Gemina Laboratories Ltd.
Gemina Laboratories Ltd.
CSE Index:
CSE CompositeCurrency:
CAD Gemina Labs is a biosensor and diagnostic company with a unique and transformative proprietary biochemistry that significantly improves the performance of human and animal testings, including COVID-19, Influenza and other viruses.
Gemina Laboratories Ltd. (GLAB)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Company Info
Address
3602 Gilmore Way
Suite 313
Burnaby, BC V5G 4W9
CanadaEmail
investor@geminalabs.comWebsite
https://www.geminalabs.com/Listing date
Tuesday, August 10, 2021Transfer Agent
Computershare Investor Services Inc.Email
investor@geminalabs.comSEDAR Information
Filing Type
Any
Timeframe
1 week1 month3 month6 month1 yearAll Time
Company Info
Address
3602 Gilmore Way
Suite 313
Burnaby, BC V5G 4W9
CanadaEmail
investor@geminalabs.comWebsite
https://www.geminalabs.com/Listing date
Tuesday, August 10, 2021Transfer Agent
Computershare Investor Services Inc.Email
investor@geminalabs.comCapitalization
Issued & Outstanding:
74574272Reserved for Issuance:
16152330Company Officers
Brian Firth, CEO
Michael Liggett, Chief Financial Officer
Robert Greene, Chief Technology Officer
News Releases
10/07/2024
Gemina Laboratories Strategic Update
Bulletins
09/08/2021
2021-0806 – New Listing - Gemina Laboratories Ltd. (GLAB)
Le 9 août/August 2021
The common shares of Gemina Laboratories Ltd. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
